Aro R, Alfthan H, Kinnula V, Leppa S: Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic variables in lung cancer. Cancer Res 2002, 62(18):5210?217. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESCAAHAWHFTFfUDoMI, Authors/Task Force Members C, Thygesen K, Alpert JS et al.: Third universal definition of myocardial infarction. J Am Coll Cardiol 2012, 60(16):1581?598. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESCAAHAWHFTFftUDoMI, Katus HA, Lindahl B, Morrow DA et al.: ThirdGharbaran et al. Journal of Hematology Oncology 2013, six:62 http://jhoonline.org/content/6/1/Page 17 of54.55.56.57.58.59.60.61.62.63.64.65.66.67.68.universal definition of myocardial infarction. Circulation 2012, 126(16):2020?035. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: Joint ESCAAHAWHFTFftUDoM: Third universal definition of myocardial infarction.Methyl 2-formyl-4-hydroxybenzoate custom synthesis Eur Heart J 2012, 33(20):2551?567. Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I, et al: Lymphopenia as a prognostic issue for general survival in sophisticated carcinomas, sarcomas, and lymphomas. Cancer Res 2009, 69(13):5383?391. Porrata LF, Ristow K, Habermann TM, Ozsan N, Dogan A, Macon W, Colgan JP, Witzig TE, Inwards DJ, Ansell SM, et al: Absolute monocyte/ lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse substantial B-cell lymphoma. Leuk Lymphoma 2012, 53(11):2159?165. Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Kim JE, Kim CW, Huh J: Prognostic significance from the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma. Am J Clin Pathol 2012, 138(6):846?54. Koh YW, Kang HJ, Park C, Yoon DH, Kim S, Suh C, Go H, Kim JE, Kim CW, Huh J: The ratio on the absolute lymphocyte count towards the absolute monocyte count is related to prognosis in Hodgkin’s lymphoma: correlation with tumor-associated macrophages. Oncologist 2012, 17(6):871?80. De Giorgi U, Mego M, Scarpi E, Giuliano M, Giordano A, Reuben JM, Valero V, Ueno NT, Hortobagyi GN, Cristofanilli M: Partnership between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer. Clin Breast Cancer 2012, 12(four):264?69. Watanabe K, Yamashita Y, Nakayama A, Hasegawa Y, Kojima H, Nagasawa T, Mori N: Varied B-cell immunophenotypes of Hodgkin/reed-Sternberg cells in classic Hodgkin’s illness. Histopathol 2000, 36(4):353?61. Carbone A, Gloghini A, Gaidano G, Franceschi S, Capello D, Drexler HG, Falini B, Dalla-Favera R: Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin’s disease. Blood 1998, 92(7):2220?228.Formula of 7-Bromochromane-3-carboxylic acid Buettner M, Greiner A, Avramidou A, Jack HM, Niedobitek G: Evidence of abortive plasma cell differentiation in Hodgkin and reed-Sternberg cells of classical Hodgkin lymphoma.PMID:23577779 Hematol Oncol 2005, 23(three?):127?32. Bai M, Panoulas V, Papoudou-Bai A, Horianopoulos N, Kitsoulis P, Stefanaki K, Rontogianni D, Agnantis NJ, Kanavaros P: B-cell differentiation immunophenotypes in classical Hodgkin lymphomas. Leuk Lymphoma 2006, 47(three):495?01. Jones RJ, Gocke CD, Kasamon YL, Miller CB, Perkins B, Barber JP, Vala MS, Gerber JM, Gellert LL, Siedner M, et al: Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood 2009, 113(23):5920?926. Ibarrola De Andres C, Toscano R, Lahuerta JJ, Martinez-.
